Join the Facial Wrinkles group to help and get support from people like you.
Facial Wrinkles News (Page 2)
Related terms: Frown Lines, Nasolabial Folds, Smile Lines, Wrinkles, Glabellar Lines, Canthal Lines, Lateral Canthal Lines
FDA Approves Skinvive by Juvéderm (hyaluronic acid) Microdroplet Injection to Improve Skin Smoothness of the Cheeks
IRVINE, Calif., May 15, 2023 /PRNewswire/ – Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the U.S. FDA approval of Skinvive™ by Juvéderm® to improve skin smoothness of the che...
FDA Approves Juvéderm Volux XC for Improvement of Jawline Definition
IRVINE, Calif., Aug. 3, 2022 /PRNewswire/ – Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the U.S. FDA approval of Juvéderm® Volux™ XC for the improvement of jawline defi...
FDA Approves Juvéderm Voluma XC For Mid-Face Injection Via Cannula
DUBLIN, Sept. 3, 2019 /PRNewswire/ – Allergan plc (NYSE: AGN) announced today it received U.S. Food and Drug Administration (FDA) approval for the use of Juvéderm Voluma XC, a hyaluronic acid gel ...
FDA Approves Jeuveau (prabotulinumtoxinA-xvfs) for Temporary Improvement in the Appearance of Frown Lines
NEWPORT BEACH, Calif., Feb. 01, 2019 (GLOBE NEWSWIRE) – Evolus, Inc. (NASDAQ: EOLS) today announced that the U.S. Food and Drug Administration (“FDA”) has approved its lead product, Jeuveau, for the ...
FDA Approves Botox Cosmetic (OnabotulinumtoxinA) for the Temporary Improvement in the Appearance of Moderate to Severe Forehead Lines
DUBLIN, Oct. 3, 2017 /PRNewswire/ – Today Allergan plc (NYSE: AGN) announced the FDA approval of Botox Cosmetic for its third indication, the temporary improvement in the appearance of moderate to...
FDA Medwatch Alert: Unintentional Injection of Soft Tissue Filler into Blood Vessels in the Face: FDA Safety Communication - Risk of Serious Patient Injury
[Posted 05/28/2015] ISSUE: The FDA has reviewed information that suggests unintentional injection of soft tissue fillers into blood vessels in the face can result in rare, but serious side effects....
FDA Medwatch Alert: Expression Injectable by Enhancement Medical: FDA Safety Communication - Adverse Events Associated with Unapproved Use As a Dermal Filler
ISSUE: The FDA has become aware of adverse events associated with the unapproved use of the Expression product, hyaluronic acid that is packaged in a syringe, as a dermal filler. Events have included...
FDA Approves Botox Cosmetic to Improve the Appearance of Crow’s Feet Lines
WEDNESDAY, September 11, 2013 – The U.S. Food and Drug Administration today approved a new use for Botox Cosmetic (onabotulinumtoxinA) for the temporary improvement in the appearance of moderate to...
FDA Medwatch Alert: Skin Creams, Soaps and Lotions Marketed as Skin Lighteners and Anti-aging Treatments: May Contain the Toxic Metal, Mercury
Issue: FDA notified healthcare professionals and warned consumers not to use skin creams, beauty and antiseptic soaps, or lotions that might contain mercury. The products are marketed as skin...
Merz Aesthetics Announces FDA Approval of Belotero Balance Dermal Filler for the Correction of Moderate-to-Severe Facial Wrinkles and Folds
SAN MATEO, Calif., November 16, 2011 – Merz Aesthetics today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Belotero Balance for the correction of...
Merz Aesthetics Announces FDA Approval Of Xeomin (incobotulinumtoxinA) For The Temporary Improvement In The Appearance Of Moderate To Severe Glabellar Lines In Adult Patients
SAN MATEO, Calif., July 21, 2011 /PRNewswire/ – Merz Aesthetics today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Xeomin (incobotulinumtoxinA) for the...
Fibrocell Science, Inc. Announces FDA Approval for laViv (azficel-T)
EXTON, Pa.--(BUSINESS WIRE)--Jun 22, 2011 - Fibrocell Science, Inc., a cell therapy company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and...